  The pharmacokinetics ( PK) , safety , and tolerability of two repeated dosing regimens of oral fosfomycin tromethamine were evaluated in 18 healthy adult subjects. Subjects received 3 g every other day ( QOD) for 3 doses and then every day ( QD) for 7 doses , or vice versa , in a phase I , randomized , open-label , two-period-crossover study. Serial blood (